These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 22589302)

  • 1. Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer.
    Straume O; Shimamura T; Lampa MJ; Carretero J; Øyan AM; Jia D; Borgman CL; Soucheray M; Downing SR; Short SM; Kang SY; Wang S; Chen L; Collett K; Bachmann I; Wong KK; Shapiro GI; Kalland KH; Folkman J; Watnick RS; Akslen LA; Naumov GN
    Proc Natl Acad Sci U S A; 2012 May; 109(22):8699-704. PubMed ID: 22589302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.
    Syed Khaja AS; Dizeyi N; Kopparapu PK; Anagnostaki L; Härkönen P; Persson JL
    PLoS One; 2013; 8(8):e72210. PubMed ID: 23991063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1.
    Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S
    PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between VEGF and MTA1 signaling pathways contribute to aggressiveness of breast carcinoma.
    Nagaraj SR; Shilpa P; Rachaiah K; Salimath BP
    Mol Carcinog; 2015 May; 54(5):333-50. PubMed ID: 24265228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype.
    Naumov GN; Bender E; Zurakowski D; Kang SY; Sampson D; Flynn E; Watnick RS; Straume O; Akslen LA; Folkman J; Almog N
    J Natl Cancer Inst; 2006 Mar; 98(5):316-25. PubMed ID: 16507828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.
    Wei L; Liu TT; Wang HH; Hong HM; Yu AL; Feng HP; Chang WW
    Breast Cancer Res; 2011 Oct; 13(5):R101. PubMed ID: 22023707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study.
    Schuster C; Akslen LA; Straume O
    PLoS One; 2016; 11(5):e0155242. PubMed ID: 27166673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer.
    Appaiah H; Bhat-Nakshatri P; Mehta R; Thorat M; Badve S; Nakshatri H
    Cancer Biol Ther; 2010 Sep; 10(6):600-14. PubMed ID: 20603605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy.
    Musiani D; Konda JD; Pavan S; Torchiaro E; Sassi F; Noghero A; Erriquez J; Perera T; Olivero M; Di Renzo MF
    FASEB J; 2014 Sep; 28(9):4055-67. PubMed ID: 24903273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
    Nasser MW; Qamri Z; Deol YS; Ravi J; Powell CA; Trikha P; Schwendener RA; Bai XF; Shilo K; Zou X; Leone G; Wolf R; Yuspa SH; Ganju RK
    Cancer Res; 2012 Feb; 72(3):604-15. PubMed ID: 22158945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells.
    Young E; Miele L; Tucker KB; Huang M; Wells J; Gu JW
    Cancer Biol Ther; 2010 Oct; 10(7):703-11. PubMed ID: 20686367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes.
    Kodama A; Sakai H; Matsuura S; Murakami M; Murai A; Mori T; Maruo K; Kimura T; Masegi T; Yanai T
    BMC Cancer; 2009 Oct; 9():363. PubMed ID: 19825192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
    Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
    Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J; Yang Q; Li J; Zhou S
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors.
    Monsky WL; Mouta Carreira C; Tsuzuki Y; Gohongi T; Fukumura D; Jain RK
    Clin Cancer Res; 2002 Apr; 8(4):1008-13. PubMed ID: 11948107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.
    Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK
    Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invading basement membrane matrix is sufficient for MDA-MB-231 breast cancer cells to develop a stable in vivo metastatic phenotype.
    Abdelkarim M; Vintonenko N; Starzec A; Robles A; Aubert J; Martin ML; Mourah S; Podgorniak MP; Rodrigues-Ferreira S; Nahmias C; Couraud PO; Doliger C; Sainte-Catherine O; Peyri N; Chen L; Mariau J; Etienne M; Perret GY; Crepin M; Poyet JL; Khatib AM; Di Benedetto M
    PLoS One; 2011; 6(8):e23334. PubMed ID: 21858074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble HSPB1 regulates VEGF-mediated angiogenesis through their direct interaction.
    Lee YJ; Lee HJ; Choi SH; Jin YB; An HJ; Kang JH; Yoon SS; Lee YS
    Angiogenesis; 2012 Jun; 15(2):229-42. PubMed ID: 22350794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
    Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2.
    Tu M; Lu C; Lv N; Wei J; Lu Z; Xi C; Chen J; Guo F; Jiang K; Li Q; Wu J; Song G; Wang S; Gao W; Miao Y
    Cancer Lett; 2016 Dec; 383(2):272-281. PubMed ID: 27702660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.